Tetsuya Otsuki

699 citations

24 papers · 561 indexed · h-index 11

Impact in

Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Oncology
- Viral-associated cancers and disorders

Papers in

Pathology and Forensic Medicine 7
- Lymphoma Diagnosis and Treatment 4
Dermatology 3
- Cutaneous lymphoproliferative disorders research 3

Co-authors: Mark Raffeld M. Vogelbruch HM Clark ES Jaffe Axel Wellmann Keiya Ozawa Johnson M. Liu Sachiko Kajigaya
Journals: Journal of Clinical Oncology (2 papers)Cancer Science (2 papers)Biochemical and Biophysical Research Communications (2 papers)Journal of Cellular Biochemistry (1 paper)Journal of Bodywork and Movement Therapies (1 paper)
Partner nations: Japan United States

In The Last Decade

Tetsuya Otsuki

24 papers receiving 543 citations

Peers

Countries citing papers authored by Tetsuya Otsuki

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Otsuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Otsuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Otsuki more than expected).

Fields of papers citing papers by Tetsuya Otsuki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Otsuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Otsuki. The network helps show where Tetsuya Otsuki may publish in the future.

Co-authors

The 25 scholars most cited alongside Tetsuya Otsuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tetsuya Otsuki Line = papers co-authored together Tetsuya Otsuki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Low back pain characteristics in adolescent patients with early-stage spondylolysis: a prospective study European Spine Journal ·言穆弘, Yasuchika Aoki, Gutiérrez Brito, Lu Zhan, P. Dańczuk, Nia Moleca Saputri, Abdulrahman Al-Awon, Tetsuya Otsuki, I Sasaki, David Steven Cañón Ramírez, Herly Jannet, Kinshi Kato, Yasushi Suwazono, J P Eylers, Seiji Ohtori, Satoru Nishikawa	2024	1
2	Safety and efficacy of aggressive exercise therapy for patients with unilateral early-stage spondylolysis: A retrospective comparative cohort study Journal of Bodywork and Movement Therapies ·言穆弘, Yasuchika Aoki, Lu Zhan, P. Dańczuk, Gutiérrez Brito, Nia Moleca Saputri, David Steven Cañón Ramírez, Abdulrahman Al-Awon, Herly Jannet, Tetsuya Otsuki, I Sasaki, J P Eylers, Seiji Ohtori, Satoru Nishikawa	2023	1
3	Active thermography inspection of CFRP using cyclic heating and Fourier transform—comparison with flash heating method Advanced Composite Materials ·Masashi Ishikawa, Xin-Yuan Zang, Hideo Nishino, Takeo Kato, Tetsuya Otsuki	2022	3
4	Utility of Physical Examination Findings for Predicting Low-Back Pain in Adolescent Patients with Early-Stage Spondylolysis: A Retrospective Comparative Cohort Study Spine Surgery and Related Research ·言穆弘, Yasuchika Aoki, Lu Zhan, P. Dańczuk, Gutiérrez Brito, Nia Moleca Saputri, David Steven Cañón Ramírez, Abdulrahman Al-Awon, Herly Jannet, Tetsuya Otsuki, Karen Westerman Kitchens, Juturu Timmasetty, J P Eylers, Seiji Ohtori, Satoru Nishikawa	2021	4
5	Evaluation of safety, pharmacokinetics, and efficacy of vorinostat, a histone deacetylase inhibitor, in the treatment of gastrointestinal (GI) cancer in a phase I clinical trial International Journal of Clinical Oncology ·Toshihiko Doi, Tetsuya Hamaguchi, Kuniaki Shirao, Shi Kangyu, Kiyohiko Hatake, Kazuo Noguchi, Tetsuya Otsuki, Anish Mehta, Atsushi Ohtsu	2012	37
6	Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma Cancer Science ·Takashi Watanabe, Harumi Kato, Yukio Kobayashi, Satoshi Yamasaki, Yuriko Morita‐Hoshi, Hiroki Yokoyama, Yasuo Morishima, Justin L. Ricker, Tetsuya Otsuki, Bernardot, Yoshihiro Matsuno, Kensei Tobinai	2009	54
7	Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors Cancer Science ·Yutaka Fujiwara, Noboru Yamamoto, Yasuhide Yamada, Kazuhiko Yamada, Tetsuya Otsuki, Pepa Cuesta Roldán, Takashi Iwasa, James S. Hardwick, Tomohide Tamura	2009	37
8	PD3-1-2: Phase I trial of vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with solid tumors Journal of Thoracic Oncology ·Yutaka Fujiwara, Noboru Yamamoto, Kazuhiko Yamada, Yasuhide Yamada, Fumiaki Koizumi, Tatsu Shimoyama, Kazuto Nishio, Tetsuya Otsuki, Stanley R. Frankel, Tomohide Tamura	2007	2
9	Phase I study of vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients (pts) with non-Hodgkin lymphoma (NHL) in Japan Journal of Clinical Oncology ·Kensei Tobinai, Takashi Watanabe, Yoshihisa Kobayashi, Satoshi Yamasaki, Yuriko Morita‐Hoshi, Hiroki Yokoyama, Y Morishima, Harumi Kato, SR Frankel, Tetsuya Otsuki	2007	5
10	Phosphorylation of Fanconi Anemia Protein, FANCA, Is Regulated by Akt Kinase Biochemical and Biophysical Research Communications ·Tetsuya Otsuki, Mira Bartok, Norio Komatsu, Keita Kirito, Yusuke Furukawa, Shinichi Kobayashi, Johnson M. Liu, Keiya Ozawa	2002	13
11	Fanconi anemia protein complex is a novel target of the IKK signalsome Journal of Cellular Biochemistry ·Tetsuya Otsuki, David B. Young, Dennis T. Sasaki, Matthew P. Pando, Jianwu Li, Anthony M. Manning, Merl F. Hoekstra, Maureen E. Hoatlin, Frank Mercurio, Johnson M. Liu	2002	19
12	Massive Immune Hemolysis After Non-myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation with Minor ABO-incompatibility Leukemia & lymphoma ·Ouiza Berdjane, Kazuo Muroi, Tohru Izumi, Masaki Toshima, Enzhu Wei, Tetsuya Otsuki, Tadashi Nagai, Norio Komatsu, Keiya Ozawa	2002	5
13	[Acute promyelocytic leukemia accompanied by retinoic acid syndrome with complications of acute myocardial infarction and cerebral infarction during treatment with all-trans retinoic acid]. PubMed ·Takuji Miyoshi, Tetsuya Otsuki, حيدر سالم محمد, Keita Kirito, Tadashi Nagai, Tohru Izumi, Norio Komatsu, Seiji Madoiwa, Jun Mimuro, Yoichi Sakata, Keiya Ozawa	2002	10
14	Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex Human Molecular Genetics ·Tetsuya Otsuki	2001	72
15	Autologous Peripheral Blood Stem Cell Transplantation for Adults with B-Lineage Acute Lymphoblastic Leukemia: A Pilot Study Leukemia & lymphoma ·Kazuo Muroi, Xianlong Cai, 邱梨芳, Minoru Yoshida, L Perdomo-soret, R. de Luis Carballada, Tetsuya Otsuki, Tohru Izumi, Hiroshi Tomizuka, Norio Komatsu, Shigehiko Imagawa, Kiyohiko Hatake, Yasusada Miura, Keiya Ozawa	2000	3
16	SNX5, a New Member of the Sorting Nexin Family, Binds to the Fanconi Anemia Complementation Group A Protein Biochemical and Biophysical Research Communications ·Tetsuya Otsuki, Sachiko Kajigaya, Keiya Ozawa, Johnson M. Liu	1999	54
17	Tumor necrosis factor-? and CD95 ligation suppress erythropoiesis in fanconi anemia C gene knockout mice Journal of Cellular Physiology ·Tetsuya Otsuki, Shoichi Nagakura, Jianxiang Wang, Michael L. Bloom, Markus Grompe, J M Liu	1999	49
18	Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells. International Journal of Hematology ·Tetsuya Otsuki	1998	9
19	Analysis of the t(2;5)(p23;q35) translocation by reverse transcription- polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease Blood ·Axel Wellmann, Tetsuya Otsuki, M. Vogelbruch, HM Clark, ES Jaffe, Mark Raffeld	1995	118
20	Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. PubMed ·Helen M. Clark, Takahiro Yano, Tetsuya Otsuki, Elaine S. Jaffe, David Shibata, Mark Raffeld	1994	58

About Tetsuya Otsuki

Tetsuya Otsuki is a scholar working on Pathology and Forensic Medicine, Dermatology, Oncology, Hematology and Occupational Therapy, having authored 24 papers that have together received 561 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (6 papers), Histone Deacetylase Inhibitors Research (6 papers), Peptidase Inhibition and Analysis (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Cutaneous lymphoproliferative disorders research (3 papers), Musculoskeletal pain and rehabilitation (3 papers), Viral-associated cancers and disorders (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (156 citations), Oncology (155 citations), Molecular Biology (383 citations), Cancer Research (76 citations) and Genetics (51 citations). Tetsuya Otsuki has collaborated with scholars based in Japan and United States. Frequent co-authors include Mark Raffeld, M. Vogelbruch, HM Clark, ES Jaffe, Axel Wellmann, Keiya Ozawa, Johnson M. Liu, Sachiko Kajigaya, Elaine S. Jaffe and Takahiro Yano. Their work appears in journals such as Journal of Clinical Oncology, Cancer Science, Biochemical and Biophysical Research Communications, Journal of Cellular Biochemistry and Journal of Bodywork and Movement Therapies.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact